Nora Brennan

This profile gathers the share dealings of Nora Brennan across 2 companies, led by Spectrum Pharmaceuticals Inc and TELA Bio, Inc. We count 11 filings; the first trade dates from 13 November 2019 and the latest from 31 July 2023.

Sales make up the whole of the open-market record (2 sales, €36k). The rest of the record consists of 6 share grants. So far in 2023, the count stands at no purchases and 1 sale.

Most recently, on 1 August 2023, the filings show a transaction in Spectrum Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.